Zhang Sheng, Li Xiang-Zhou, Zeng Zhao-Yan
College of Materials Science and Engineering, Central South University of Forestry and Technology, Changsha, 410004, China.
State Key Laboratory of Ecological Applied Technology in Forest Area of South China, Changsha, 410004, China.
Curr Drug Deliv. 2018 Feb 14;15(2):247-253. doi: 10.2174/1567201814666170621113953.
Due to its excellent adsorption capability, activated carbon(AC) has also been employed as a drug carrier. However, applications of the AC carrier in traditional Chinese medicine (TCM) have been rare. We selected the Eucommia ulmoides leaf extract as the drug of choice and AC as its carrier, to investigate the adsorption and sustained release behavior of the Eucommia ulmoides leaf extract on the AC.
AC was employed in this study as the sustained release carrier and its capability for adsorption and sustained release of Eucommia ulmoides leaf extracts was systematically investigated. Acid or alkali modified AC was assessed for its ability to absorb and sustain release of Eucommia ulmoides leaf extracts according to a variety of adsorption/release rate and composition.
Results demonstrated that the adsorption rate for the differently modified AC reached above 80 %, whereas the adsorption of Eucommia ulmoides leaf extracts on the AC was selective. The composition of the sustained release liquid, which was treated by the acid modified AC, was almost similar to the original extract. The acid modified AC was therefore taken as an optimal carrier that can be used for Eucommia ulmoides leaf extracts sustained release.
The synchronous release and absorption of different ingredients in the active ingredient release process ensures the global and cooperative effect with sustained and less toxic advantages. The ideal synchronous release is that the absorbed component proportion is consistent with its release. The acid modified AC was therefore taken as the optimal carrier that can be used for Eucommia ulmoides leaf extracts sustained release.
由于具有出色的吸附能力,活性炭(AC)也被用作药物载体。然而,AC载体在中药(TCM)中的应用却很少见。我们选择杜仲叶提取物作为首选药物,并以AC作为其载体,来研究杜仲叶提取物在AC上的吸附和缓释行为。
本研究采用AC作为缓释载体,并系统地研究了其对杜仲叶提取物的吸附和缓释能力。根据多种吸附/释放速率和组成,评估了酸碱改性AC对杜仲叶提取物的吸收和缓释能力。
结果表明,不同改性AC的吸附率达到80%以上,而杜仲叶提取物在AC上的吸附具有选择性。经酸改性AC处理的缓释液组成与原提取物几乎相似。因此,酸改性AC被视为可用于杜仲叶提取物缓释的最佳载体。
活性成分释放过程中不同成分的同步释放和吸收确保了整体协同效应,具有持续且低毒的优势。理想的同步释放是吸收成分比例与其释放比例一致。因此,酸改性AC被视为可用于杜仲叶提取物缓释的最佳载体。